Which Is the Optimal Biologically Effective Dose of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer? A Meta-Analysis

Title
Which Is the Optimal Biologically Effective Dose of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer? A Meta-Analysis
Authors
Keywords
-
Journal
Publisher
Elsevier BV
Online
2011-06-21
DOI
10.1016/j.ijrobp.2011.04.034

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started